| 1 | 1-20190 | - | - | - | - | 0931件: 93 💬 | 
| 2 | 11c-csar | - | - | - | - | 0932件: 93, 94 💬 | 
| 3 | 13-15mg/kg/d ursodeoxycholic | - | - | - | - | 0931件: 93 💬 | 
| 4 | 18-22mg/kg/d ursodeoxycholic | - | - | - | - | 0931件: 93 💬 | 
| 5 | 3 mg [14c]-a4250 capsule | - | - | - | - | 0932件: 93, 297 💬 | 
| 6 | 3a,7a-dihydroxy-6a-ethyl-5betacholan-24-oic acid | - | - | - | - | 0931件: 93 💬 | 
| 7 | 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-oic acid | - | - | - | - | 0931件: 93 💬 | 
| 8 | 6 alpha-ethylchenodeoxycholic acid (6-edca), oca, int-747 | - | - | - | - | 0931件: 93 💬 | 
| 9 | 6-ecdca | Obeticholic acid | 1件: D09360D09360 💬 | NR1H41件: NR1H4 💬 | Bile secretion1件: Bile secretion | 0931件: 93 💬 | 
| 10 | 6-ethylchenodeoxycholic acid | Obeticholic acid | 1件: D09360D09360 💬 | NR1H41件: NR1H4 💬 | Bile secretion1件: Bile secretion | 0931件: 93 💬 | 
| 11 | 6?-ethylchenodeoxycholic acid (6-ecdca), oca, int-747 | Obeticholic acid | 1件: D09360D09360 💬 | NR1H41件: NR1H4 💬 | Bile secretion1件: Bile secretion | 0931件: 93 💬 | 
| 12 | 6a-ethylchenodeoxycholic acid (6-ecdca), oca, int-747 | Obeticholic acid | 1件: D09360D09360 💬 | NR1H41件: NR1H4 💬 | Bile secretion1件: Bile secretion | 0931件: 93 💬 | 
| 13 | 6a-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid | Obeticholic acid | 1件: D09360D09360 💬 | NR1H41件: NR1H4 💬 | Bile secretion1件: Bile secretion | 0931件: 93 💬 | 
| 14 | 6a-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5betacholan-24-o | Obeticholic acid | 1件: D09360D09360 💬 | NR1H41件: NR1H4 💬 | Bile secretion1件: Bile secretion | 0931件: 93 💬 | 
| 15 | 6a-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5betacholan-24-o, obeticholic acid (oca) | Obeticholic acid | 1件: D09360D09360 💬 | NR1H41件: NR1H4 💬 | Bile secretion1件: Bile secretion | 0931件: 93 💬 | 
| 16 | 6a-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-o | Obeticholic acid | 1件: D09360D09360 💬 | NR1H41件: NR1H4 💬 | Bile secretion1件: Bile secretion | 0931件: 93 💬 | 
| 17 | 6a-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-o, obeticholic acid (oca) | Obeticholic acid | 1件: D09360D09360 💬 | NR1H41件: NR1H4 💬 | Bile secretion1件: Bile secretion | 0931件: 93 💬 | 
| 18 | 6a-ethylchenodeoxycholic acid, 6-ethylchenodeoxycholic acid | Obeticholic acid | 1件: D09360D09360 💬 | NR1H41件: NR1H4 💬 | Bile secretion1件: Bile secretion | 0931件: 93 💬 | 
| 19 | 6a-ethylchenodeoxycholic acid, 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5betacholan-24-o | Obeticholic acid | 1件: D09360D09360 💬 | NR1H41件: NR1H4 💬 | Bile secretion1件: Bile secretion | 0931件: 93 💬 | 
| 20 | 6a-ethylchenodeoxycholic acid, 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5betacholan-24-o , obeticholic acid (oca) | Obeticholic acid | 1件: D09360D09360 💬 | NR1H41件: NR1H4 💬 | Bile secretion1件: Bile secretion | 0931件: 93 💬 | 
| 21 | 6a-ethylchenodeoxycholic acid, 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-o | Obeticholic acid | 1件: D09360D09360 💬 | NR1H41件: NR1H4 💬 | Bile secretion1件: Bile secretion | 0931件: 93 💬 | 
| 22 | 6a-ethylchenodeoxycholic acid, 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-o , obeticholic acid (oca) | Obeticholic acid | 1件: D09360D09360 💬 | NR1H41件: NR1H4 💬 | Bile secretion1件: Bile secretion | 0931件: 93 💬 | 
| 23 | A11ha02 | - | - | - | - | 0931件: 93 💬 | 
| 24 | A4250 | - | - | - | - | 0933件: 93, 296, 297 💬 | 
| 25 | Abatacept | Abatacept | 1件: D03203D03203 💬 | CD802件: CD80, CD86 💬 | Allograft rejection12件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis | 01126件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬 | 
| 26 | Acido obeticolico | - | - | - | - | 0932件: 93, 94 💬 | 
| 27 | Acido ursodessicolico | - | - | - | - | 0931件: 93 💬 | 
| 28 | Alkaline phosphatase | Alkaline Phosphatase | - | - | - | 0464件: 46, 93, 97, 172 💬 | 
| 29 | Apd334 | - | - | - | - | 0934件: 93, 96, 97, 269 💬 | 
| 30 | Atorvastatin | Atorvastatin | 3件: D00258D00258, D00887D00887, D07474D07474 💬 | HMGCR1件: HMGCR 💬 | AMPK signaling pathway4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis | 01317件: 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 💬 | 
| 31 | Baricitinib | Baricitinib | 1件: D10308D10308 💬 | JAK12件: JAK1, JAK2 💬 | AGE-RAGE signaling pathway in diabetic complications33件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis | 0419件: 41, 46, 49, 50, 93, 107, 265, 268, 325 💬 | 
| 32 | Bcd-085 | - | - | - | - | 0932件: 93, 271 💬 | 
| 33 | Bezafibrat | - | - | - | - | 0931件: 93 💬 | 
| 34 | Bezafibrat genericon retard 400 mg | - | - | - | - | 0931件: 93 💬 | 
| 35 | Bezafibrate | Bezafibrate | 1件: D01366D01366 💬 | PPARA1件: PPARA 💬 | Adipocytokine signaling pathway8件: Adipocytokine signaling pathway, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway | 0206件: 20, 93, 94, 160, 316, 324 💬 | 
| 36 | Bezafibrate 200 mg | Bezafibrate | 1件: D01366D01366 💬 | PPARA1件: PPARA 💬 | Adipocytokine signaling pathway8件: Adipocytokine signaling pathway, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway | 0931件: 93 💬 | 
| 37 | Bezafibrate 400 mg | Bezafibrate | 1件: D01366D01366 💬 | PPARA1件: PPARA 💬 | Adipocytokine signaling pathway8件: Adipocytokine signaling pathway, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway | 0931件: 93 💬 | 
| 38 | Bezafibrate ir | Bezafibrate | 1件: D01366D01366 💬 | PPARA1件: PPARA 💬 | Adipocytokine signaling pathway8件: Adipocytokine signaling pathway, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway | 0931件: 93 💬 | 
| 39 | Bezafibrate sr | Bezafibrate | 1件: D01366D01366 💬 | PPARA1件: PPARA 💬 | Adipocytokine signaling pathway8件: Adipocytokine signaling pathway, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway | 0931件: 93 💬 | 
| 40 | Bezafibrate, beza, bzf, bezalip | Bezafibrate | 1件: D01366D01366 💬 | PPARA1件: PPARA 💬 | Adipocytokine signaling pathway8件: Adipocytokine signaling pathway, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway | 0931件: 93 💬 | 
| 41 | Bezafibrate, beza, bzf, bezalip mono | Bezafibrate | 1件: D01366D01366 💬 | PPARA1件: PPARA 💬 | Adipocytokine signaling pathway8件: Adipocytokine signaling pathway, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway | 0931件: 93 💬 | 
| 42 | Bezalip | - | - | - | - | 0933件: 93, 94, 160 💬 | 
| 43 | Bezalip mono | - | - | - | - | 0931件: 93 💬 | 
| 44 | Biological: mesenchymal stem cell | - | - | - | - | 0931件: 93 💬 | 
| 45 | Budenofalk 3mg | - | - | - | - | 0932件: 93, 97 💬 | 
| 46 | Budesonide | Budesonide | 1件: D00246D00246 💬 | NR3C11件: NR3C1 💬 | Neuroactive ligand-receptor interaction1件: Neuroactive ligand-receptor interaction | 0669件: 66, 93, 94, 95, 96, 97, 98, 228, 299 💬 | 
| 47 | Calcium | Calcium | - | - | - | 00627件:  6 , 13, 19, 46, 49, 51, 53, 56, 68, 75, 79, 84, 93, 94, 95, 96, 97, 186, 214, 215, 222, 224, 235, 265, 274, 298, 299 💬 | 
| 48 | Choline | Choline | 1件: D07690D07690 💬 | - | - | 0934件: 93, 171, 193, 299 💬 | 
| 49 | Cilofexor | Cilofexor | - | - | - | 0932件: 93, 94 💬 | 
| 50 | Cnto1275 | - | - | - | - | 0466件: 46, 49, 84, 93, 96, 97 💬 | 
| 51 | Colchicine | Colchicine | 1件: D00570D00570 💬 | TUBB9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 | Alzheimer disease10件: Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection | 0027件:  2 , 42, 46, 56, 93, 210, 266 💬 | 
| 52 | Combination antiviral therapy | - | - | - | - | 0931件: 93 💬 | 
| 53 | Cr845 1.0 mg | - | - | - | - | 0931件: 93 💬 | 
| 54 | Crc (a3384) | - | - | - | - | 0932件: 93, 297 💬 | 
| 55 | Cyclophosphamide | Cyclophosphamide | 2件: D00287D00287, D07760D07760 💬 | - | - | 01144件: 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 222, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 💬 | 
| 56 | Cyclosporin | Cyclosporine | 1件: D00184D00184 💬 | PPP3CA5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | Alzheimer disease32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway | 03817件: 38, 46, 49, 50, 53, 56, 60, 62, 63, 93, 95, 97, 113, 164, 222, 274, 326 💬 | 
| 57 | Cyclosporin a | Cyclosporine | 1件: D00184D00184 💬 | PPP3CA5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | Alzheimer disease32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway | 04611件: 46, 49, 53, 56, 60, 62, 63, 93, 95, 113, 164 💬 | 
| 58 | Denosumab | Denosumab | 1件: D03684D03684 💬 | TNFSF111件: TNFSF11 💬 | Breast cancer7件: Breast cancer, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis | 0467件: 46, 50, 93, 95, 96, 274, 299 💬 | 
| 59 | Device: fibroscan | - | - | - | - | 0931件: 93 💬 | 
| 60 | E6011 | - | - | - | - | 0463件: 46, 93, 96 💬 | 
| 61 | Edp-305 | - | - | - | - | 0931件: 93 💬 | 
| 62 | Edp-305 dose 1 | - | - | - | - | 0931件: 93 💬 | 
| 63 | Edp-305 dose 2 | - | - | - | - | 0931件: 93 💬 | 
| 64 | Elafibranor | Elafibranor | 1件: D11208D11208 💬 | PPARA1件: PPARA 💬 | Adipocytokine signaling pathway8件: Adipocytokine signaling pathway, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway | 0931件: 93 💬 | 
| 65 | Elafibranor 120 mg | Elafibranor | 1件: D11208D11208 💬 | PPARA1件: PPARA 💬 | Adipocytokine signaling pathway8件: Adipocytokine signaling pathway, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway | 0931件: 93 💬 | 
| 66 | Elafibranor 80 mg | Elafibranor | 1件: D11208D11208 💬 | PPARA1件: PPARA 💬 | Adipocytokine signaling pathway8件: Adipocytokine signaling pathway, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway | 0931件: 93 💬 | 
| 67 | Elafibranor 80mg | Elafibranor | 1件: D11208D11208 💬 | PPARA1件: PPARA 💬 | Adipocytokine signaling pathway8件: Adipocytokine signaling pathway, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway | 0931件: 93 💬 | 
| 68 | Emtricitabine | Emtricitabine | 1件: D01199D01199 💬 | - | - | 0254件: 25, 93, 265, 325 💬 | 
| 69 | Emtricitabine (ftc)/tenofovir disoproxil (tdf) | Emtricitabine | 3件: D01199D01199, D01982D01982, D06074D06074 💬 | - | - | 0931件: 93 💬 | 
| 70 | Experimental: seladelpar / mbx-8025 200 mg | MBX-8025 | - | - | - | 0931件: 93 💬 | 
| 71 | Experimental: seladelpar / mbx-8025 50 mg | MBX-8025 | - | - | - | 0931件: 93 💬 | 
| 72 | Ezetimibe | Ezetimibe | 1件: D01966D01966 💬 | NPC1L11件: NPC1L1 💬 | Fat digestion and absorption1件: Fat digestion and absorption | 0494件: 49, 79, 93, 260 💬 | 
| 73 | Ezetrol | - | - | - | - | 0932件: 93, 260 💬 | 
| 74 | Ezt | - | - | - | - | 0931件: 93 💬 | 
| 75 | Fenofibrate | Fenofibrate | 1件: D00565D00565 💬 | PPARA1件: PPARA 💬 | Adipocytokine signaling pathway8件: Adipocytokine signaling pathway, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway | 0085件:  8 , 79, 93, 94, 265 💬 | 
| 76 | Fenofibrate idd-p (insoluble drug delivery-micro particle) | Fenofibrate | 1件: D00565D00565 💬 | PPARA1件: PPARA 💬 | Adipocytokine signaling pathway8件: Adipocytokine signaling pathway, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway | 0931件: 93 💬 | 
| 77 | Ffp104 | - | - | - | - | 0932件: 93, 96 💬 | 
| 78 | Fully human monoclonal antibody directed against cxcl10 | - | - | - | - | 0931件: 93 💬 | 
| 79 | Fuzhenghuayu | - | - | - | - | 0931件: 93 💬 | 
| 80 | Gft505 | - | - | - | - | 0931件: 93 💬 | 
| 81 | Gkt137831 | - | - | - | - | 0852件: 85, 93 💬 | 
| 82 | Gold | Gold | - | - | - | 00238件:  2 ,  5 ,  6 , 13, 17, 34, 46, 49, 50, 53, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 158, 162, 171, 218, 222, 224, 227, 230, 271, 291, 294, 296, 298, 299, 310, 318 💬 | 
| 83 | Gs-9674 | - | - | - | - | 0932件: 93, 94 💬 | 
| 84 | Gs-9674 100 mg | - | - | - | - | 0931件: 93 💬 | 
| 85 | Gs-9674 30 mg | - | - | - | - | 0931件: 93 💬 | 
| 86 | Gsk2330672 | - | - | - | - | 0931件: 93 💬 | 
| 87 | High protein high fiber diet | - | - | - | - | 0932件: 93, 95 💬 | 
| 88 | Htd1801 (budca) | - | - | - | - | 0931件: 93 💬 | 
| 89 | Icg | - | - | - | - | 0932件: 93, 94 💬 | 
| 90 | Int-747 | - | - | - | - | 0931件: 93 💬 | 
| 91 | Int-747, oca | - | - | - | - | 0932件: 93, 94 💬 | 
| 92 | Kaletra | - | - | - | - | 0931件: 93 💬 | 
| 93 | Linerixibat | - | - | - | - | 0931件: 93 💬 | 
| 94 | Linerixibat (gsk2330672) 45mg | - | - | - | - | 0931件: 93 💬 | 
| 95 | Liver biopsy | - | - | - | - | 0931件: 93 💬 | 
| 96 | Ljn452 | - | - | - | - | 0931件: 93 💬 | 
| 97 | Ljn452, 0,01 mg | - | - | - | - | 0931件: 93 💬 | 
| 98 | Ljn452, 0,03 mg | - | - | - | - | 0931件: 93 💬 | 
| 99 | Ljn452, 0,1 mg | - | - | - | - | 0931件: 93 💬 | 
| 100 | Lum001 | - | - | - | - | 0933件: 93, 94, 297 💬 | 
| 101 | Ly3009104 | - | - | - | - | 0466件: 46, 49, 50, 93, 107, 325 💬 | 
| 102 | Mabthera | - | - | - | - | 01122件: 11, 13, 14, 19, 35, 43, 44, 46, 49, 50, 51, 52, 53, 61, 63, 64, 65, 83, 93, 162, 222, 271 💬 | 
| 103 | Mabthera® | - | - | - | - | 0136件: 13, 35, 43, 44, 46, 93 💬 | 
| 104 | Magnesium | Magnesium | - | - | - | 00616件:  6 , 11, 13, 46, 64, 70, 93, 97, 166, 225, 235, 284, 291, 296, 297, 298 💬 | 
| 105 | Mbx 8025 | - | - | - | - | 0931件: 93 💬 | 
| 106 | Mbx-8025 | MBX-8025 | - | - | - | 0793件: 79, 93, 94 💬 | 
| 107 | Mbx-8025 10 mg capsule | MBX-8025 | - | - | - | 0931件: 93 💬 | 
| 108 | Mbx-8025 2 mg capsule | MBX-8025 | - | - | - | 0931件: 93 💬 | 
| 109 | Mbx-8025 5 mg capsule | MBX-8025 | - | - | - | 0931件: 93 💬 | 
| 110 | Mbx-8025, dsic | MBX-8025 | - | - | - | 0931件: 93 💬 | 
| 111 | Mbx-8025, formulation 2 | MBX-8025 | - | - | - | 0931件: 93 💬 | 
| 112 | Methionine | Methionine | 2件: D00019D00019, D04983D04983 💬 | - | - | 0347件: 34, 75, 84, 93, 229, 298, 300 💬 | 
| 113 | Methotrexate | Methotrexate | 2件: D00142D00142, D02115D02115 💬 | DHFR2件: DHFR, DHFR2 💬 | Antifolate resistance5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate | 01135件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 271, 284, 285, 326, 331 💬 | 
| 114 | Minodronic acid | Minodronic acid | - | - | - | 0064件:  6 , 46, 93, 95 💬 | 
| 115 | Modafinil | Modafinil | 1件: D01832D01832 💬 | - | - | 0064件:  6 , 13, 49, 93 💬 | 
| 116 | Moexipril | Moexipril | 2件: D00623D00623, D08225D08225 💬 | ACE1件: ACE 💬 | Chagas disease6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system | 0931件: 93 💬 | 
| 117 | Mycophenolate | Mycophenolic acid | 1件: D05096D05096 💬 | IMPDH12件: IMPDH1, IMPDH2 💬 | Drug metabolism - other enzymes3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism | 00234件:  2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 84, 85, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 💬 | 
| 118 | Mycophenolate mofetil | Mycophenolate mofetil | 4件: D00752D00752, D05094D05094, D05095D05095, D05096D05096 💬 | IMPDH12件: IMPDH1, IMPDH2 💬 | Drug metabolism - other enzymes3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism | 00232件:  2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 85, 93, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 💬 | 
| 119 | Ngm282 | - | - | - | - | 0932件: 93, 94 💬 | 
| 120 | Ni-0801 | - | - | - | - | 0931件: 93 💬 | 
| 121 | Non-myeloablative hematopoietic stem cell transplantation | - | - | - | - | 0931件: 93 💬 | 
| 122 | Obeticholic acid | Obeticholic acid | 1件: D09360D09360 💬 | NR1H41件: NR1H4 💬 | Bile secretion1件: Bile secretion | 0933件: 93, 265, 296 💬 | 
| 123 | Obeticholic acid (oca) | Obeticholic acid | 1件: D09360D09360 💬 | NR1H41件: NR1H4 💬 | Bile secretion1件: Bile secretion | 0931件: 93 💬 | 
| 124 | Oca (int-747) | - | - | - | - | 0931件: 93 💬 | 
| 125 | Oca, int-747 | - | - | - | - | 0931件: 93 💬 | 
| 126 | Ocaliva | - | - | - | - | 0932件: 93, 296 💬 | 
| 127 | Ocaliva 10mg | - | - | - | - | 0931件: 93 💬 | 
| 128 | Ocaliva 5mg | - | - | - | - | 0931件: 93 💬 | 
| 129 | Olumiant | - | - | - | - | 0464件: 46, 49, 93, 107 💬 | 
| 130 | Op-724 | - | - | - | - | 0931件: 93 💬 | 
| 131 | Other: blood samples | - | - | - | - | 0931件: 93 💬 | 
| 132 | Other: questionnaires | - | - | - | - | 0065件:  6 , 13, 41, 93, 96 💬 | 
| 133 | Part 1: ljn452 | - | - | - | - | 0931件: 93 💬 | 
| 134 | Part 2: ljn452 dose level 1 | - | - | - | - | 0931件: 93 💬 | 
| 135 | Part 2: ljn452 dose level 2 | - | - | - | - | 0931件: 93 💬 | 
| 136 | Pemafibrate | Pemafibrate | 1件: D10711D10711 💬 | PPARA1件: PPARA 💬 | Adipocytokine signaling pathway8件: Adipocytokine signaling pathway, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway | 0931件: 93 💬 | 
| 137 | Pentoxifylline | Pentoxifylline | 1件: D00501D00501 💬 | - | - | 02610件: 26, 56, 84, 93, 96, 113, 220, 222, 296, 298 💬 | 
| 138 | Phenylbutyrate | Phenylbutyric acid | 1件: D05868D05868 💬 | - | - | 00211件:  2 ,  3 ,  6 ,  8 , 15, 93, 94, 244, 251, 297, 299 💬 | 
| 139 | Prednisone | Prednisone | 1件: D00473D00473 💬 | NR3C11件: NR3C1 💬 | Neuroactive ligand-receptor interaction1件: Neuroactive ligand-receptor interaction | 00247件:  2 ,  6 , 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 81, 84, 85, 86, 93, 95, 96, 97, 113, 127, 162, 164, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 💬 | 
| 140 | Probiotic | - | - | - | - | 0027件:  2 ,  6 , 93, 96, 97, 193, 266 💬 | 
| 141 | Pyridoxine | Pyridoxine | 2件: D02179D02179, D08454D08454 💬 | - | - | 0932件: 93, 145 💬 | 
| 142 | Pyridoxine 10mg | Pyridoxine | 2件: D02179D02179, D08454D08454 💬 | - | - | 0931件: 93 💬 | 
| 143 | Pyridoxine 10mg bp | Pyridoxine | 2件: D02179D02179, D08454D08454 💬 | - | - | 0931件: 93 💬 | 
| 144 | Questran | - | - | - | - | 0933件: 93, 254, 297 💬 | 
| 145 | Raltegravir | Raltegravir | 1件: D06676D06676 💬 | - | - | 0134件: 13, 26, 93, 265 💬 | 
| 146 | Rhudex 100 mg (127 mg rhudex choline salt) granules | Choline | 1件: D07690D07690 💬 | - | - | 0931件: 93 💬 | 
| 147 | Rhudex 25 mg (31.75 mg rhudex choline salt) granules | Choline | 1件: D07690D07690 💬 | - | - | 0931件: 93 💬 | 
| 148 | Rhudex 50 mg (63.5 mg rhudex choline salt) granules | Choline | 1件: D07690D07690 💬 | - | - | 0931件: 93 💬 | 
| 149 | Rhudex choline salt | Choline | 1件: D07690D07690 💬 | - | - | 0931件: 93 💬 | 
| 150 | Rifampicin | Rifampicin | 1件: D00211D00211 💬 | - | - | 0065件:  6 , 17, 46, 93, 299 💬 | 
| 151 | Risedronic acid | Risedronic acid | 3件: D00942D00942, D03234D03234, D08484D08484 💬 | FDPS1件: FDPS 💬 | Human T-cell leukemia virus 1 infection4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis | 0933件: 93, 95, 274 💬 | 
| 152 | Rituximab | Rituximab | 1件: D02994D02994 💬 | MS4A11件: MS4A1 💬 | Hematopoietic cell lineage1件: Hematopoietic cell lineage | 01147件: 11, 13, 14, 17, 19, 35, 36, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬 | 
| 153 | S-adenosyl-l-methionine | Methionine | 2件: D00019D00019, D04983D04983 💬 | - | - | 0931件: 93 💬 | 
| 154 | S-adenosyl-methionine (same) capsules | Ademetionine | 3件: D00019D00019, D04983D04983, D07128D07128 💬 | - | - | 0931件: 93 💬 | 
| 155 | Same | Ademetionine | 1件: D07128D07128 💬 | - | - | 0931件: 93 💬 | 
| 156 | Saroglitazar | Saroglitazar | - | - | - | 0931件: 93 💬 | 
| 157 | Saroglitazar magnesium 2 mg | Magnesium | - | - | - | 0931件: 93 💬 | 
| 158 | Saroglitazar magnesium 4 mg | Magnesium | - | - | - | 0931件: 93 💬 | 
| 159 | Seladelpar | - | - | - | - | 0932件: 93, 94 💬 | 
| 160 | Seladelpar 10 mg | - | - | - | - | 0931件: 93 💬 | 
| 161 | Seladelpar 10 mg capsule | - | - | - | - | 0931件: 93 💬 | 
| 162 | Seladelpar 5 mg | - | - | - | - | 0931件: 93 💬 | 
| 163 | Seladelpar 5 mg capsule | - | - | - | - | 0931件: 93 💬 | 
| 164 | Seladelpar 5-10 mg | - | - | - | - | 0931件: 93 💬 | 
| 165 | Sortis | - | - | - | - | 0931件: 93 💬 | 
| 166 | Sortis 10 mg | - | - | - | - | 0931件: 93 💬 | 
| 167 | Sublimated mare milk | - | - | - | - | 0931件: 93 💬 | 
| 168 | Tauroursodeoxycholic acid | Tauroursodeoxycholic acid | 1件: D11836D11836 💬 | - | - | 0024件:  2 , 13, 93, 299 💬 | 
| 169 | Tauroursodeoxycholic acid capsules | Tauroursodeoxycholic acid | 1件: D11836D11836 💬 | - | - | 0931件: 93 💬 | 
| 170 | Tenofovir | Tenofovir | 1件: D06074D06074 💬 | - | - | 0025件:  2 , 25, 93, 265, 325 💬 | 
| 171 | Tenofovir disoproxil | Tenofovir | 2件: D01982D01982, D06074D06074 💬 | - | - | 0932件: 93, 265 💬 | 
| 172 | Tetrathiomolybdate | Tetrathiomolybdate | - | - | - | 0853件: 85, 93, 171 💬 | 
| 173 | Tigecycline | Tigecycline | 1件: D01079D01079 💬 | - | - | 0931件: 93 💬 | 
| 174 | Tqa3526 | - | - | - | - | 0931件: 93 💬 | 
| 175 | Tropifexor | Tropifexor | 1件: D11548D11548 💬 | NR1H41件: NR1H4 💬 | Bile secretion1件: Bile secretion | 0931件: 93 💬 | 
| 176 | Truvada and kaletra | - | - | - | - | 0931件: 93 💬 | 
| 177 | Udca | Ursodeoxycholic acid | 1件: D00734D00734 💬 | NR1H41件: NR1H4 💬 | Bile secretion1件: Bile secretion | 0675件: 67, 93, 94, 97, 296 💬 | 
| 178 | Udca (ursodeoxycholic acid) | Ursodeoxycholic acid | 1件: D00734D00734 💬 | NR1H41件: NR1H4 💬 | Bile secretion1件: Bile secretion | 0931件: 93 💬 | 
| 179 | Umbilical cord derived mesenchymal stem cell (uc -msc) transplantation | - | - | - | - | 0932件: 93, 296 💬 | 
| 180 | Ursodeoxycholic acid | Ursodeoxycholic acid | 1件: D00734D00734 💬 | NR1H41件: NR1H4 💬 | Bile secretion1件: Bile secretion | 0068件:  6 , 67, 84, 93, 94, 95, 96, 97 💬 | 
| 181 | Ursodeoxycholic acid (urso) | Ursodeoxycholic acid | 1件: D00734D00734 💬 | NR1H41件: NR1H4 💬 | Bile secretion1件: Bile secretion | 0931件: 93 💬 | 
| 182 | Ursodeoxycholic acid 300mg capsule | Ursodeoxycholic acid | 1件: D00734D00734 💬 | NR1H41件: NR1H4 💬 | Bile secretion1件: Bile secretion | 0931件: 93 💬 | 
| 183 | Ursodeoxycholic acid 300mg tablet | Ursodeoxycholic acid | 1件: D00734D00734 💬 | NR1H41件: NR1H4 💬 | Bile secretion1件: Bile secretion | 0931件: 93 💬 | 
| 184 | Ursodeoxycholic acid capsules | Ursodeoxycholic acid | 1件: D00734D00734 💬 | NR1H41件: NR1H4 💬 | Bile secretion1件: Bile secretion | 0931件: 93 💬 | 
| 185 | Ursodeoxycholic acid combination of immunosuppressive agents | Ursodeoxycholic acid | 1件: D00734D00734 💬 | NR1H41件: NR1H4 💬 | Bile secretion1件: Bile secretion | 0932件: 93, 95 💬 | 
| 186 | Ursodeoxycholic acid combined with total glucosides of paeony | Ursodeoxycholic acid | 1件: D00734D00734 💬 | NR1H41件: NR1H4 💬 | Bile secretion1件: Bile secretion | 0931件: 93 💬 | 
| 187 | Ursodeoxycholic acid only | Ursodeoxycholic acid | 1件: D00734D00734 💬 | NR1H41件: NR1H4 💬 | Bile secretion1件: Bile secretion | 0931件: 93 💬 | 
| 188 | Ursodeoxycholic acid+low dose glucocorticoid(prednisone) | Prednisone | 2件: D00473D00473, D00734D00734 💬 | NR1H42件: NR1H4, NR3C1 💬 | Bile secretion2件: Bile secretion, Neuroactive ligand-receptor interaction | 0931件: 93 💬 | 
| 189 | Ursodeoxycholsäure | - | - | - | - | 0931件: 93 💬 | 
| 190 | Ursodiol | Ursodeoxycholic acid | 1件: D00734D00734 💬 | NR1H41件: NR1H4 💬 | Bile secretion1件: Bile secretion | 0086件:  8 , 20, 93, 97, 234, 299 💬 | 
| 191 | Ursofalk | - | - | - | - | 0934件: 93, 94, 96, 97 💬 | 
| 192 | Ursofalk® 500 mg film-coated tablets | - | - | - | - | 0931件: 93 💬 | 
| 193 | Ursofalk® 500 mg filmtabletten | - | - | - | - | 0931件: 93 💬 | 
| 194 | Ursofalk® capsules | - | - | - | - | 0931件: 93 💬 | 
| 195 | Ustekinumab | Ustekinumab | 1件: D09214D09214 💬 | IL12A3件: IL12A, IL12B, IL23A 💬 | African trypanosomiasis26件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus | 03715件: 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬 | 
| 196 | Ustekinumab 180 mg | Ustekinumab | 1件: D09214D09214 💬 | IL12A3件: IL12A, IL12B, IL23A 💬 | African trypanosomiasis26件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus | 0931件: 93 💬 | 
| 197 | Ustekinumab 45 mg | Ustekinumab | 1件: D09214D09214 💬 | IL12A3件: IL12A, IL12B, IL23A 💬 | African trypanosomiasis26件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus | 0931件: 93 💬 | 
| 198 | Ustekinumab 90 mg | Ustekinumab | 1件: D09214D09214 💬 | IL12A3件: IL12A, IL12B, IL23A 💬 | African trypanosomiasis26件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus | 0494件: 49, 50, 93, 96 💬 | 
| 199 | Vitamin d | Vitamin D | - | - | - | 01321件: 13, 19, 41, 43, 44, 46, 49, 50, 68, 93, 95, 96, 97, 98, 179, 222, 228, 235, 274, 298, 299 💬 | 
| 200 | Zoledronic acid | Zoledronic acid | 4件: D01968D01968, D06378D06378, D06379D06379, D08689D08689 💬 | FDPS1件: FDPS 💬 | Human T-cell leukemia virus 1 infection4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis | 0069件:  6 , 13, 46, 93, 95, 96, 274, 299, 333 💬 |